Skip to content

Echocardiographic Assessment of the Impact of Diabetes and Prognostic Analysis of Heart Transplantation

A Multicenter Clinical Study of Echocardiographic Evaluation of the Impact of Diabetes and Prognostic Analysis of Heart Transplantation

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04976517
Enrollment
1500
Registered
2021-07-26
Start date
2021-08-01
Completion date
2024-03-31
Last updated
2021-07-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Transplant

Brief summary

The aim of this study is to evaluat the impact of diabetes on cardiac function in patients with heart transplantation by multimodal imaging and analyse their prognosis.

Detailed description

This study is planed to enroll 300000 patients after heart transplantation, all the patients will be divided into 3 groups according to whether or not they have diabetes and when did they develop diabete. Echocardiography will be used to evaluat their cardiac function. Comparing their cardiac function and clinical information and analysing their prognosis to evaluat the impact of diabetes.

Interventions

None listed

Sponsors

Second Affiliated Hospital, School of Medicine, Zhejiang University
CollaboratorOTHER
Shanghai Zhongshan Hospital
CollaboratorOTHER
Wuhan Asia Heart Hospital
CollaboratorOTHER
Guangdong Provincial People's Hospital
CollaboratorOTHER
Henan Provincial People's Hospital
CollaboratorOTHER
Xie Mingxing
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients who received a heart transplant after 2015

Exclusion criteria

* The image quality is poor

Design outcomes

Primary

MeasureTime frameDescription
all-cause mortalityup to 2023.12death from all causes
acute rejectionup to 2023.12acute rejection required treatment
readmissionup to 2023.12readmission from all causes

Contacts

Primary ContactLi Zhang, PhD
zli429@hust.edu.cn18907131488

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026